REYON Pharmaceutical Co., Ltd. (KRX:102460)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,320
+400 (4.03%)
Jul 14, 2026, 3:30 PM KST
Market Cap181.94B -12.3%
Revenue (ttm)145.22B -1.9%
Net Income-40.59B
EPS-2,202.86
Shares Out 18.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume110,326
Open9,710
Previous Close9,920
Day's Range9,710 - 10,590
52-Week Range9,100 - 13,200
Beta0.43
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ... [Read more]

Sector Healthcare
Founded 1955
Employees 440
Stock Exchange Korea Stock Exchange
Ticker Symbol 102460
Full Company Profile

Financial Performance

Financial Statements